Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immuron Ltd ADR (NQ: IMRN )

2.059 -0.041 (-1.93%)
Streaming Delayed Price Updated: 2:28 PM EST, Jan 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Immuron Ltd ADR

Immuron US DoD Naval Medical Research Center responds to FDA Clinical Hold for New Campylobacter ETEC Therapeutic
From Immuron Limited
Via Globe NewsWire
US Department of Defense Uniformed Services University Clinical Evaluation of Travelan™ Achieves 150 Recruitment Milestone
From Immuron Limited
Via Globe NewsWire
Immuron Receives European Patent on Drug Composition to Treat Clostridioides difficile Associated Disease
From Immuron Limited
Via Globe NewsWire
Immuron Receives FDA Approval for Travelan IND Application
From Immuron Limited
Via Globe NewsWire
Immuron Submits IND Application To FDA for Travelan
From Immuron Limited
Via Globe NewsWire
Immuron completes strategic investment in leading gut health biotech Ateria Health
From Immuron Limited
Via Globe NewsWire
Immuron CEO, Steven Lydeamore to present at AusBioInvest
From Immuron Limited
Via Globe NewsWire
Immuron strategic investment in leading gut health biotech Ateria Health
From Immuron Limited
Via Globe NewsWire
Immuron Executes Travelan Clinical Trial Agreement with US-based Pharmaron
From Immuron Limited
Via Globe NewsWire
Immuron US DoD Naval Medical Research Center Receives feedback on IND Application for New Campylobacter ETEC Therapeutic
From Immuron Limited
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.